IndietroPulmonary Embolism: Pathophysiology, Diagnosis, and Treatment
Guida di studio - Note intelligenti
Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.
Disorders of Pulmonary Circulation
Pulmonary Embolism Overview
Pulmonary embolism (PE) is a critical disorder of pulmonary circulation characterized by the obstruction of blood flow within the pulmonary arteries. This condition can range from asymptomatic presentations to sudden death, depending on the size and location of the embolus and the patient's underlying cardiopulmonary status.
Definition: Mechanical obstruction of blood flow in the pulmonary arteries, most commonly due to thrombotic emboli.
Types of Emboli:
Thrombotic (most common; usually from deep vein thrombosis)
Fat emboli (e.g., long bone fracture)
Air embolism
Amniotic fluid embolism (e.g., ruptured membranes)
Clinical Range: Asymptomatic to sudden death
Filtering Function: Pulmonary vasculature filters venous blood, preventing particles from entering arterial circulation
Tolerance: Patients without significant cardiopulmonary disease can tolerate up to 1/3 occlusion of lung perfusion before hemodynamic compromise occurs
Thrombotic Embolism
Thrombotic emboli are the most common cause of PE and originate outside the pulmonary circulation, typically from the deep veins of the lower extremities.
Origin: Lower extremities (popliteal, femoral, iliac veins)
Calf thrombi: Less associated with PE
Upper extremity thrombi: Less common
Example: Saddle embolus at pulmonary artery bifurcation
Risk Factors for Thromboembolism
Risk factors for PE are classified into three main categories: venous stasis, hypercoagulable states, and vascular damage.
Risk | Examples |
|---|---|
Venous stasis | Bed-ridden/prolonged hospitalization or nursing home, paralysis/spinal cord injury, lengthy travel (> 4 hours) |
Hypercoagulable | Genetics (Factor V Leiden, prothrombin mutations, protein C and S deficiency), family history, active cancer, estrogen therapy, obesity, pregnancy, antiphospholipid syndrome |
Vascular damage | Trauma, surgery (especially orthopedic), central venous catheter placement |
Ventilation/Perfusion (V/Q) Mismatch in PE
PE leads to mismatches between ventilation and perfusion, resulting in hypoxemia and impaired gas exchange.
Low V/Q: Vasoconstricted units lose perfusion, leading to decreased surfactant production and alveolar collapse
Dead space ventilation: Ventilation of blocked/vasoconstricted units (high V/Q)
Compensation: Pulmonary arterial pressure (PAP) increases blood flow to normal units
Shunt: Very low V/Q, resulting in hypoxemia
Pathophysiology of Pulmonary Embolism
The pathophysiological effects of PE involve hemodynamics, gas exchange, and the work of breathing.
Category | Mechanism |
|---|---|
Hemodynamics | ↑ Pulmonary vascular resistance due to vascular obstruction and vasoconstriction (thromboxane A2, serotonin) |
Gas Exchange | Hypoxemia (↓ PaO2) from perfusion of low V/Q units and decreased cardiac output; alveolar dead space from vascular obstruction and perfusion of high V/Q units |
Work of Breathing | ↓ Lung compliance (↓ surfactant production, edema, alveolar hemorrhage); ↑ Airway resistance (reflex bronchoconstriction); Tachypnea (stimulation of irritant receptors, response to hypoxia) |
Clinical Presentation
PE presents with a variety of respiratory, hemodynamic, and hypoxemic symptoms. Evidence of deep vein thrombosis (DVT) is present in about 70% of cases.
Respiratory (cardinal symptoms):
Sudden onset dyspnea
Bronchoconstriction (wheezing), crackles on lung auscultation
Tachypnea (shallow breathing)
Pleuritic chest pain due to alveolar hemorrhage
Hemoptysis (coughing up blood)
Hemodynamic:
↑ Pulmonary artery pressure (pulmonary hypertension)
↓ Cardiac output (with large emboli or saddle embolus)
Near-syncope or syncope
Tachycardia
Hypoxemia:
V/Q mismatch
Low PaO2
Lactic acidosis
Evidence of DVT: Positive D-dimer (lab), swelling/redness/pain in lower extremities
Clinical Presentation: Massive Pulmonary Emboli
Massive PE is characterized by significant or absolute loss of cardiac output and presents with severe symptoms.
Sudden collapse/death
Low blood pressure (shock)
Loss of consciousness
Crushing substernal chest pain
Rapid, weak pulse
Cyanosis
Jugular venous congestion (JVD)
Diagnosis of Pulmonary Embolism
Diagnosis of PE involves clinical suspicion, laboratory testing, and imaging studies.
Clinical suspicion: Only ~20% of suspected cases are confirmed
If low risk: D-dimer test (high sensitivity, low specificity)
If high risk: Pulmonary imaging
Imaging Modalities for PE Diagnosis
CT Pulmonary Angiography (CTPA): First-line imaging; requires contrast medium injection (contraindicated in renal insufficiency or allergy)
Ventilation/Perfusion (V/Q) Scan: Uses inhaled and injected radioisotope to assess perfusion abnormalities
Treatment of Pulmonary Embolism
Treatment depends on hemodynamic stability and includes anticoagulation and, in severe cases, thrombolysis.
Hemodynamically stable:
Anticoagulation: Warfarin, Heparin (IV; initial/bridge therapy), Low Molecular Weight Heparins (Enoxaparin), Factor Xa inhibitors (Rivaroxaban, Apixaban)
Hemodynamically unstable (SBP < 90 mmHg):
Thrombolysis followed by anticoagulation
Alteplase (tissue plasminogen activator): degrades fibrin clot
Key Equations and Concepts
Alveolar Gas Equation:
V/Q Ratio: Describes the relationship between ventilation (V) and perfusion (Q) in the lung
Additional info: The notes have been expanded to include definitions, mechanisms, and clinical context for each topic, as well as relevant equations and tables for exam preparation.